Efficacy of intravascular ultrasound-guided percutaneous coronary intervention in patients with acute myocardial infarction

作     者：苏智友 黄培森 陈振锋 梁永强 蔡京海 郭群花 邓雪娇 叶素媛 黄碧珍 SU Zhi-you;HUANG Pei-sen;CHEN Zhen-feng;LIANG Yong-qiang;CAI Jing-hai;GUO Qun-hua;DENG Xue-jiao;YE Su-yuan;HUANG Bi-zhen

作者机构：Huaiji County People's Hospital in GuangdongZhaoqing CityGuangdong Province 526451China 

出 版 物：《South China Journal of Cardiology》 (岭南心血管病杂志（英文版）)

年 卷 期：2024年第25卷第2期

页      面：109-116页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：supported by the Zhaoqing City Science and Technology Innovation Guidance Project(No.2023010309025) 

主　　题：Intravascular ultrasound Percutaneous coronary intervention Acute myocardial infarction Major adversecardiovascularevents 

摘      要：Background The intravascular ultrasound(IVUS)-guided percutaneous coronary intervention(PCI)can benefit the treatment of coronary artery disease(CAD).However,the beneficial effect of IVUS-guided PCI in patients with acute myocardial infarction(AMI)remains *** A total of 537 AMI patients were included in this study,divided into two groups:the angiography-guided group(n=289)and the IVUS-guided group(n=248)according to whether the IVUS was *** primary outcome was a composite of major adverse cardiovascular events(MACEs),including cardiovascular death,recurrent myocardial infarction(MI),and target lesion revascularization(TLR).The secondary outcome was procedural radiation exposure *** The IVUS-guided group was associated with a reduced incidence of MACEs(12.8%vs.8.5%,P=0.032).The results were consistent after adjusting for confounders in the multivariable Cox analysis,which showed that the absence of IVUS(HR 1.194,95%CI 1.061-1.323,P=0.011)was an independent predictor of ***,the IVUS-guided group experienced significantly lower float time(893.3±265.2 min vs.623.2±137.3 min,P0.001).Conclusions The use of IVUS was associated with better long-term cardiovascular *** use of IVUS in PCI should be considered for patients with AMI to optimize procedural outcomes and enhance long-term prognosis.